Janany Sabes
@glomerican.bsky.social
📤 374
📥 560
📝 30
Assistant Professor of Medicine, UofR Nephrologist by Day / Muggle by night
reposted by
Janany Sabes
Nephrology Journal Club
14 days ago
Hey
#NephSky
2/10/26 at 9 pm EST we'll discuss
#Flozinating
into the Future & Beyond... SGLT2i in kidney transplant recipients. What's the latest evidence of risk/benefit? Do
#Flozins
act mechanistically the same in de-innervated kidneys? Come chat.
www.nephjc.com/news/inifinti-flozins-transplant
loading . . .
To INFINITI and Beyond: SGLT2 Inhibitors in Kidney Transplant Patients — NephJC
This week, we aim for an INFINITe allograft lifespan. or flozination in kidney transplant.
https://www.nephjc.com/news/inifinti-flozins-transplant
0
9
10
reposted by
Janany Sabes
Nephrology Journal Club
13 days ago
Here is the VA for the INFINITI study of SGLT2i in transplant patients by
@glomerican.bsky.social
#NephSky
#Flozins
#Flozination
www.nephjc.com/news/2026/2/8/infiniti-the-visual-abstract
loading . . .
INFINITI: The Visual Abstract — NephJC
SGLT2i have reshaped cardiorenal care, but kidney transplant recipients have mostly been left out of the story. INFINITI starts to close that gap, testing the safety and physiology of dapagliflozin in...
https://www.nephjc.com/news/2026/2/8/infiniti-the-visual-abstract
0
12
10
reposted by
Janany Sabes
Nephrology Journal Club
26 days ago
Up next on #NephJC we will be unpacking SGLT2i in transplant recipients👇
journals.lww.com/cja...
#NephJC
0
9
4
reposted by
Janany Sabes
Nephrology Journal Club
27 days ago
Oh, the weather outside is frightful 🥶🥶 But
#NephJC
is so delightful, and since you've no place to go
#NephSky
... Come discuss POTCAST: potassium goals and cardiac arrhythmias 1/27/26 at 9pm EST on
#Bluesky
Summary by
@shelliefravel.bsky.social
@salinesolut.bsky.social
www.nephjc.com/news/potcast
loading . . .
POTCAST- K+ Pop and Arrhythmia Drop — NephJC
This week, we will discuss the POTCAST trial. It is a cardiology trial - but potassium belongs to nephrology.
https://www.nephjc.com/news/potcast
2
13
10
reposted by
Janany Sabes
Nephrology Journal Club
about 1 month ago
⏰2 hours until
#NephJC
chat Join us today to learn more about the recently released VALIANT study, which investigates the use of Pegcetacoplan in C3 glomerulonephropathy and immune complex mediated glomerulonephritis
0
5
4
reposted by
Janany Sabes
Nephrology Journal Club
about 1 month ago
Wilst thou join us here, where the Sky is Blue?
#NephJC
On 1/13/26 at 9pm EST 'tis true We shall converse of the great knight's quest, a VALIANT effort from Sir Pegcetacoplan vs complement! ⚔️
www.nephjc.com/news/valiant-c3g
loading . . .
A VALIANT effort to combat complement disorders with pegcetacoplan — NephJC
This week, we will discuss the VALIANT study, pegcetacoplan in C3G and IC MPGN.
https://www.nephjc.com/news/valiant-c3g
0
9
6
Tis the season for christmas kidney cookies! Happy Holidays
2 months ago
1
5
1
reposted by
Janany Sabes
Nephrology Journal Club
2 months ago
1/10 Last
#NephJC
we discussed dialysis frequency in AKI-D
#TenPostNephJC
We sought to answer an age-old question: Is less is really more? Or less is just simply what it is….less?
pubmed.ncbi.nlm.nih.gov/41201895/
1
8
8
reposted by
Janany Sabes
Nephrology Journal Club
2 months ago
Join us for the last
#NephJC
of 2025, 12/16/25 at 9pm EST!🥳 How soon should we withhold dialysis in AKI? We're discussing the LIBERATE-D trial
#NephSky
This one might just change your mind 🧠🧠 Blog by
@msocomd.bsky.social
and
@sejalplakhani.bsky.social
www.nephjc.com/news/liberated-aki
loading . . .
Dialyze Less, Recover More? AKI’s Chance to Get LIBERATE-D — NephJC
This week, we will discuss whether less is more when it comes to discontinuing dialysis in patients with AKI and a chance to recover.
https://www.nephjc.com/news/liberated-aki
2
12
13
reposted by
Janany Sabes
Nephrology Journal Club
2 months ago
1/10 Welcome to
#TenPostNephJC
Last
#NephJC
we discussed the PISCES study 🐟 on the role of fish oil on cardiovascular events in hemodialysis patients. This study was presented at Kidney Week with simultaneous publication, and was as unexpected as a shark attack🦈.
1
8
8
reposted by
Janany Sabes
Nephrology Journal Club
3 months ago
Maybe the most shocking study from
#KidneyWk
. 🐚From the depths of the oceans to
#BlueSky
, we're discussing PISCES 🐟 12/2/25 9pm EST.
#NephJC
Are you hooked🪝on fish oil for CV disease in ESRD, or are you throwing it back 🌊?
www.nephjc.com/news/pisces-fishoil
loading . . .
Fish Oil in Dialysis: A Big Catch or an Empty Net — NephJC
Holy Mackerel! This week we will discuss fish oil use in maintenance hemodialysis patients. Could this be the one thing that bends the curve on CV mortality, or is it just a red herring?
https://www.nephjc.com/news/pisces-fishoil
0
20
19
reposted by
Janany Sabes
Nephrology Journal Club
3 months ago
Holy Mackerel! 🐟 🦜Ahoy matey! Could fish oil unlock the mysteries of increased CV mortality in ESRD? 🏴☠️
#NephJC
Join us for a lively trawling trip 12/2/25 🛥️at 9pm EST Check out the PISCES VA by
@brianrifkin.bsky.social
www.nephjc.com/news/piscesva
loading . . .
PISCES: The Visual Abstract — NephJC
Curious how n-3 PUFAs may cut serious cardiovascular events in dialysis? 🐟 A big signal, a big dose, and a big discussion ahead — don’t miss this #NephJC! Check out the VA made by our master Brian...
https://www.nephjc.com/news/piscesva
0
14
12
reposted by
Janany Sabes
Nephrology Journal Club
3 months ago
Tonite 11/18/25 on
#Bluesky
9pm EST We are discussing ORIGIN3 and atacicept in IgAN. APRIL, BAFF and B-cells, Oh My! (🦁🐯🐻) It's going to be Wicked good. 🧙♀️
#NephJC
Summary by
@notjustdialysis.bsky.social
www.nephjc.com/news/atacicept-origin3-gtfb36
loading . . .
Attacking the Origin of IgAN: ORIGIN3 and Atacicept — NephJC
This week, we will discuss the phase 3 ORIGIN3 trial of atacicept, an APRIL/BAFF inhibitor for use in IgAN.
https://www.nephjc.com/news/atacicept-origin3-gtfb36
0
12
11
reposted by
Janany Sabes
American Journal of Preventive Cardiology
4 months ago
🚨 New study alert: The American Heart Association’s latest “Cardiovascular-Kidney-Metabolic Syndrome” (CKM) metrics reveal major implications for life expectancy in U.S. adults. Dive into the full life-table analysis 👉
https://ow.ly/MtOT50XkE9P
#CardioSky
#MedSky
0
5
4
reposted by
Janany Sabes
Nephrology Journal Club
4 months ago
The 2025
@kdigo.org
IgAN guideline quietly redraws the map: new drugs, new thresholds, and a sense that the era of “supportive care only” is finally over
#Nephsky
#Medsky
✍️Summary by
@thekidneywhisperer.bsky.social
and
@glomerican.bsky.social
www.nephjc.com/news/igan-kd...
loading . . .
2025 IgAN KDIGO guidelines: fresh out of press, already aging gracefully — NephJC
This week, we will discuss the 2025 KDIGO IgAN guidelines. which the shift from supportive care to structured, evidence-based therapy
https://www.nephjc.com/news/igan-kdigo-2025
1
22
16
Hap-Pee Halloween Friends !!
#kidneyjokes
#kidneypuns
#halloween2025
4 months ago
0
0
0
reposted by
Janany Sabes
Nephrology Journal Club
4 months ago
⏩ Next
#NephJC
is on IgA nephropathy
@kdigo.org
guideline 🎨 Nice visual summary by
@roxnonna23.bsky.social
www.nephjc.com/news/2025/10...
loading . . .
KDIGO 2025 IgA guidelines - Visual Abstract — NephJC
KDIGO 2025 is here. IgAN management is evolving with precision risk tools, new therapies, and a stronger focus on kidney protection. Check out the visual abstract created by Natalia Nombera
https://www.nephjc.com/news/2025/10/27/kdigo-2025-iga-guidelines-visual-abstract
0
20
18
reposted by
Janany Sabes
Nephrology Journal Club
4 months ago
1/10 Last #NephJC we tried to answer the question whether protein supplementation increases health related QoL 🥩💊#TenPostNephJC . Read the article 👇
pubmed.ncbi.nlm.nih....
#NephJC
1
8
6
reposted by
Janany Sabes
Edgar V. Lerma 🇵🇭
5 months ago
Decision support for PICC Line placement in patients with CKD ca. 2023
#Nephpearls
#VascularAccessPearls
#NephSky
#VisualGraphic
by
@brianrifkin.bsky.social
👉🏼
pubmed.ncbi.nlm.nih.gov/34218708/
1
4
3
reposted by
Janany Sabes
Nephrology Journal Club
5 months ago
Chimerism might just be the 🔑 to immune tolerance and ending the need for immunosuppression 🚫💊after transplantation 🫘. Join the discussion 9/30/25 at 9 pm EST on Bluesky
#NephSky
#MedSky
#NephJC
www.nephjc.com/news/chimera-tolerance-njqe334
loading . . .
Chimerism and Immune Tolerance: Can We Says Goodbye to Immunosuppression? — NephJC
This week, we will discuss the use of creating chimeras to induce immune tolerance and its potential to decrease or eliminate the need for immunosuppression in kidney transplant recipients.
https://www.nephjc.com/news/chimera-tolerance-njqe334
0
17
14
reposted by
Janany Sabes
Nephrology Journal Club
5 months ago
It's that time of year again 🍂🍂🍂 The
#NephJC
Fall pledge drive. Plese give if you are able to support our decades long mission of
#FOAMed
for all.
#NephSky
#MedSky
www.nephjc.com/news/2025/9/22/nephjc-fall-pledge-drive
loading . . .
NephJC 2025 Fall Pledge Drive — NephJC
Help keep NephJC a vital, original, and unbiased source of medical education.
https://www.nephjc.com/news/2025/9/22/nephjc-fall-pledge-drive
0
16
14
reposted by
Janany Sabes
7 months ago
#GlomConHawaii
2025 🌴🌊 session: EMBARK Awareness - Closing the Gaps: Unmet Needs and Rising Opportunities for Community Education and Engagement Register here 👉
glomconhawaii.org
#GlomConHawaii2025
#GlomConHawaii
#GlomCon
1
0
1
reposted by
Janany Sabes
Nephrology Journal Club
5 months ago
❤️Check out the VA for the discussion on the AHA/ACC Hypertension Guidelines 9/16/25 at 9pm EST by
@sejalplakhani.bsky.social
#NephJC
#NephSky
#MedSky
www.nephjc.com/news/2025/9/ahaacc-htnguide
loading . . .
The AHA/ACC 2025 Hypertension Guidelines visual abstract — NephJC
New updated guidance on hypertension including screening for secondary causes, use of renal denervation, hypertension and pregnancy, risk assessment, monitoring and treatment. Check out this wonderfu...
https://www.nephjc.com/news/2025/9/ahaacc-htnguide
0
19
17
reposted by
Janany Sabes
Swapnil Hiremath 🍁🇨🇦
5 months ago
Agree with this algorithm from
evidence.nejm.org/doi/full/10....
($$$ or sub reqd) Flozinate and Glipinate Metformin only if these are not appropriate or possible All else comes later
2
8
3
reposted by
Janany Sabes
Brian Rifkin
6 months ago
Join us
#NephJC
#NephSky
add a skeleton here at some point
2
2
4
reposted by
Janany Sabes
Nephrology Journal Club
6 months ago
Check out the ACHIEVE visual abstract by
@nephromommy-akshu.bsky.social
www.nephjc.com/news/2025/8/...
loading . . .
The ACHIEVE visual abstract — NephJC
the use of spironolactone in patients on dialysis did not alter mortality or hospitalizations for heart failure. Similar results were seen in the simultaneously released ALCHEMY trial.
http://www.nephjc.com/news/2025/8/the-achieve-trial-visual-abstract-jjaw5
1
10
8
reposted by
Janany Sabes
Nephrology Journal Club
7 months ago
T0b Expert opinion—not RCTs—has dominated guidelines on phosphorus control in ESRD for decades. Why? Because phosphate feels like a villain... but is it really? 🦹♂️ I can feel it in my bones.
#NephJC
2
8
2
reposted by
Janany Sabes
Nephrology Journal Club
7 months ago
Check the insightful #NephJC summary by Akshaya Jayachandran @nephromommy-akshu.bsky.social, Natalia Nombera @roxnonna23.bsky.social, Janany Sabescumar @glomerican.bsky.social
www.nephjc.com/news/...
#NephJC
1
9
3
reposted by
Janany Sabes
Nephrology Journal Club
7 months ago
On 7/22/25 at 9pm EST only on Bluesky!
#NephSky
#MedSky
join us for a lively discussion. We're debating eGFRdiff (the gap that is sometimes present between the eGFR of cystatin C and creatinine). What does it mean, what causes it and what you should do about it.
#NephJC
www.nephjc.com/news/egfrdiff
loading . . .
Mind The Gap: When eGFR Creatinine and Cystatin C Disagree — NephJC
This week, we will discuss the clinical significance of eGFRdiff, the difference in eGFRcys (cystatin C) and eGFRcr (creatinine).
https://www.nephjc.com/news/egfrdiff
0
37
23
reposted by
Janany Sabes
Alicja Rosołowska
8 months ago
As always the
@nephjc.bsky.social
summer book turns out to be a great and fascinating read. Highly recommended.
add a skeleton here at some point
0
13
7
reposted by
Janany Sabes
Nephrology Journal Club
8 months ago
🎨Check out the beautiful
#visualabstract
by
#NephJC
intern
@shelliefravel.bsky.social
⏰Chat happening on July 8, 9 pm EST
www.nephjc.com/news/2025/7/...
loading . . .
CONFIDENCE Visual Abstract — NephJC
Check out the beautiful visual abstract made by NephJC intern Michelle Fravel .
https://www.nephjc.com/news/2025/7/8/confidence-visual-abstract
1
16
18
reposted by
Janany Sabes
Nephrology Journal Club
8 months ago
1/10 Last
#NephJC
we discussed tacrolimus (TAC) versus mycophenolate mofetil (MMF) for the treatment of pediatric nephrotic syndrome. A first👶to👶immunosuppression study for SSNS in kids
#TenPostNephJC
. Read the articles 👇
pmc.ncbi.nlm.nih.gov/articles/PMC...
1
7
9
reposted by
Janany Sabes
Swapnil Hiremath 🍁🇨🇦
8 months ago
The class of 2025,
#NephJC
interns
www.nephjc.com/news/2025/6/...
3
34
18
Another year another group of fellows leave the nest! Congratulations Annuj and Mumin!
8 months ago
0
1
0
reposted by
Janany Sabes
Nephrology Journal Club
9 months ago
Major Trials in the use of ASIs targeting difficult-to-control hypertension
#NephJC
1
18
9
reposted by
Janany Sabes
Stephanie Torres
8 months ago
NephJC Internship 2025 Kick-Off! Let's do this!!
@nephjc.bsky.social
0
9
5
First collaborative Nephrology/Endocrinology Shark Tank, so proud of our fellows and thanks to our panelist of expert judges!
9 months ago
0
1
0
Women in Medicine Book Club event and the lovely author Dr. Jessi Gold
#HowDoYouFeel
12 months ago
0
0
0
reposted by
Janany Sabes
Brendon Neuen
about 1 year ago
Prevent kidney failure to reduce carbon emissions ♻️ 🍃 🏭 Our new analysis of CREDENCE assessing environmental impacts from ⬇️ hospitalisations & dialysis 🏥 with SGLT2i SGLT2i ⬇️ greenhouse gas emissions from inpatient bed days & dialysis by 20% (39 kg CO2e per yr)
www.thelancet.com/journals/lan...
0
12
7
you reached the end!!
feeds!
log in